Dr Luka Dragacevic

Education:

2022 Ph.D. in Biochemistry, Faculty of Chemistry, University of Belgrade
2018 Specialist academic studies– Biological Drugs, Faculty of Pharmacy, University of Belgrade
2012 B.Sc. in Molecular Biology and Physiology, Faculty of Biology, University of Belgrade

Research Experience:

2023 Research Assistant, Research and Science Division, Institute of Virology, Vaccines, and Sera “Torlak”
2020 Research Trainee, Institute of Virology, Vaccines, and Sera “Torlak”

Work Experience:

2023 Acting Director of the Institute of Virology, Vaccines and Sera “Torlak”
2019 –2023 Research Assistant, Research and Science Division, Institute of Virology, Vaccines, and Sera “Torlak”
2017 –2019 Head of the Department for Influenza Vaccine Production, Institute of Virology, Vaccines, and Sera “Torlak”
2013 –2017 Associate in the Department for Influenza Vaccine Production, Institute of Virology, Vaccines, and Sera “Torlak”
2012 – 2013 Associate in the Department for Tetanus Vaccine Production, Institute of Virology, Vaccines, and Sera “Torlak”

Involvement in projects:

2023 Science Fund Project within the PROMIS programme „Role of macroautophagy in lipid nanoparticle mRNA delivery and adjuvanticity“ (REDIRECT)
2023 Horizon Europe Project “From Insightful Science to Innovative Health: Strengthening Translational Capacity and Talent Interoperability in Vaccine and Biologic Research & innovation” HORIZON-WIDERA-2022-TALENTS-03-01 No. 101120507
2022 mRNA Vaccine Technology Transfer Project, supported by the World Health Organization, the Medicines Patent Pool (MPP), and Afrigen Biologics (PTY) Limited.
2013 –2019 World Health Organization project for the production of influenza vaccines, WHO Global Action Plan for Influenza – technology transfer, validation process, preclinical and clinical trials

Other activities:

Consultant at the Laboratory for Bioengineering, Institute of Information Technologies, University of Kragujevac – establishment of the laboratory for SARS-CoV-2 diagnostics within the BioINGLab COVID-19 project, awarded for the best-prepared project in 2020, financially supported by the Government of the Republic of Serbia following the decision of the commission.

Field of Scientific Interest:

Vaccine production
Gene cloning and expression